Background Image
Background Image
Background Image
Background Image

Lyzor Therapeutics

AI-guided bacteriophage matching

Lyzor Therapeutics

AI-guided bacteriophage matching

The Story of Us

Phage therapy has a bottleneck: matching.

Finding a phage that works against a specific bacterial isolate still relies on slow, brute-force wet-lab screening. Labs may need to test many candidates over several days before finding a useful hit.

We built a prediction model for E. coli phage-host matching to help labs prioritize the most promising phages before screening begins.

Our goal is to make isolate-specific phage matching faster, cheaper, and scalable, especially for multidrug-resistant E. coli, where time matters.

how it works
how it works

Explore Our Phage Selection Process

Explore Our Phage Selection Process

We are building a prediction layer for precision phage therapy. From bacterial isolate to ranked phage candidates.

We are building a prediction layer for precision phage therapy. From bacterial isolate to ranked phage candidates.

Step 1
Illustration
Input

E.coli genome sequence, genomes of phages that you want to test (optional)

Step 1
Illustration
Input

E.coli genome sequence, genomes of phages that you want to test (optional)

Step 2
Illustration
Analysis

Annotation and genomic feature extraction

Step 2
Illustration
Analysis

Annotation and genomic feature extraction

Step 3
Illustration
Inference

ML model predicts interaction outcome

Step 3
Illustration
Inference

ML model predicts interaction outcome

Step 4
Illustration
Output

Probability of lysis for a given E.coli input + phage candidate list

Step 4
Illustration
Output

Probability of lysis for a given E.coli input + phage candidate list

ABOUT US

Meet the Team

Meet the Team

A cross-disciplinary team built for execution, combining computational biology, molecular biology, software engineering, and commercial strategy to advance AI-guided phage matching from prediction to validation.

A cross-disciplinary team built for execution, combining computational biology, molecular biology, software engineering, and commercial strategy to advance AI-guided phage matching from prediction to validation.

Lorena Derežanin, PhD

Co-founder and CEO

Zoltán Marić

CTO

Sandra Kolundžija, PhD

R&D, CSO

Mateja Sigur

Co-founder and COO

Background Image
Background Image
Background Image
Background Image

Lyzor Therapeutics

AI-guided bacteriophage matching

The Story of Us

Phage therapy has a bottleneck: matching.

Finding a phage that works against a specific bacterial isolate still relies on slow, brute-force wet-lab screening. Labs may need to test many candidates over several days before finding a useful hit.

We built a prediction model for E. coli phage-host matching to help labs prioritize the most promising phages before screening begins.

Our goal is to make isolate-specific phage matching faster, cheaper, and scalable, especially for multidrug-resistant E. coli, where time matters.

how it works

Explore Our Phage Selection Process

We are building a prediction layer for precision phage therapy. From bacterial isolate to ranked phage candidates.

Step 1
Illustration
Input

E.coli genome sequence, genomes of phages that you want to test (optional)

Step 2
Illustration
Analysis

Annotation and genomic feature extraction

Step 3
Illustration
Inference

ML model predicts interaction outcome

Step 4
Illustration
Output

Probability of lysis for a given E.coli input + phage candidate list

ABOUT US

Meet the Team

A cross-disciplinary team built for execution, combining computational biology, molecular biology, software engineering, and commercial strategy to advance AI-guided phage matching from prediction to validation.

Lorena Derežanin, PhD

Co-founder and CEO

Zoltán Marić

CTO

Sandra Kolundžija, PhD

R&D, CSO

Mateja Sigur

Co-founder and COO

Create a free website with Framer, the website builder loved by startups, designers and agencies.